Logo image of AZRN.AS

AZERION GROUP N.V. (AZRN.AS) Stock Fundamental Analysis

AMS:AZRN - Euronext Amsterdam - NL00150006Z9 - Common Stock - Currency: EUR

1.684  +0.01 (+0.84%)

Fundamental Rating

1

Taking everything into account, AZRN scores 1 out of 10 in our fundamental rating. AZRN was compared to 23 industry peers in the Interactive Media & Services industry. AZRN may be in some trouble as it scores bad on both profitability and health. AZRN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AZRN had negative earnings in the past year.
AZRN had a positive operating cash flow in the past year.
AZRN.AS Yearly Net Income VS EBIT VS OCF VS FCFAZRN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -7.46%, AZRN is doing worse than 65.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of -70.23%, AZRN is doing worse than 85.00% of the companies in the same industry.
Industry RankSector Rank
ROA -7.46%
ROE -70.23%
ROIC N/A
ROA(3y)-9.2%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AZRN.AS Yearly ROA, ROE, ROICAZRN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 100 -100

1.3 Margins

The Gross Margin of AZRN (31.01%) is worse than 90.00% of its industry peers.
The Profit Margin and Operating Margin are not available for AZRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AZRN.AS Yearly Profit, Operating, Gross MarginsAZRN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 20 -20

More info and screens

0

2. Health

2.1 Basic Checks

AZRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
AZRN has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, AZRN has an improved debt to assets ratio.
AZRN.AS Yearly Shares OutstandingAZRN.AS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M 80M 100M
AZRN.AS Yearly Total Debt VS Total AssetsAZRN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 200M 400M 600M

2.2 Solvency

AZRN has an Altman-Z score of 0.81. This is a bad value and indicates that AZRN is not financially healthy and even has some risk of bankruptcy.
AZRN has a worse Altman-Z score (0.81) than 65.00% of its industry peers.
The Debt to FCF ratio of AZRN is 24.87, which is on the high side as it means it would take AZRN, 24.87 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 24.87, AZRN is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
AZRN has a Debt/Equity ratio of 3.29. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of AZRN (3.29) is worse than 85.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.29
Debt/FCF 24.87
Altman-Z 0.81
ROIC/WACCN/A
WACC10.13%
AZRN.AS Yearly LT Debt VS Equity VS FCFAZRN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.84 indicates that AZRN may have some problems paying its short term obligations.
With a Current ratio value of 0.84, AZRN is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
A Quick Ratio of 0.84 indicates that AZRN may have some problems paying its short term obligations.
AZRN has a Quick ratio of 0.84. This is amonst the worse of the industry: AZRN underperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
AZRN.AS Yearly Current Assets VS Current LiabilitesAZRN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for AZRN have decreased strongly by -259.26% in the last year.
The Revenue has decreased by -7.11% in the past year.
EPS 1Y (TTM)-259.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-117.78%
Revenue 1Y (TTM)-7.11%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%15.02%

3.2 Future

The Earnings Per Share is expected to decrease by -10.61% on average over the next years. This is quite bad
AZRN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.94% yearly.
EPS Next Y-189.29%
EPS Next 2Y-47.6%
EPS Next 3Y-10.61%
EPS Next 5YN/A
Revenue Next Year3.55%
Revenue Next 2Y6.13%
Revenue Next 3Y6.94%
Revenue Next 5YN/A

3.3 Evolution

AZRN.AS Yearly Revenue VS EstimatesAZRN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 200M 400M 600M
AZRN.AS Yearly EPS VS EstimatesAZRN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.05 -0.05 0.1 -0.1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AZRN. In the last year negative earnings were reported.
Also next year AZRN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AZRN.AS Price Earnings VS Forward Price EarningsAZRN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AZRN indicates a somewhat cheap valuation: AZRN is cheaper than 70.00% of the companies listed in the same industry.
75.00% of the companies in the same industry are more expensive than AZRN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.9
EV/EBITDA 8.95
AZRN.AS Per share dataAZRN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

AZRN's earnings are expected to decrease with -10.61% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-47.6%
EPS Next 3Y-10.61%

More info and screens

0

5. Dividend

5.1 Amount

AZRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AZERION GROUP N.V.

AMS:AZRN (2/5/2025, 5:12:24 PM)

1.684

+0.01 (+0.84%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)11-19 2024-11-19/bmo
Earnings (Next)N/A N/A
Inst Owners0.03%
Inst Owner ChangeN/A
Ins Owners33.54%
Ins Owner ChangeN/A
Market Cap206.91M
Analysts42.22
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-285.68%
Min EPS beat(2)-426.8%
Max EPS beat(2)-144.56%
EPS beat(4)0
Avg EPS beat(4)-311.68%
Min EPS beat(4)-605.88%
Max EPS beat(4)-69.48%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.49%
Min Revenue beat(2)4.68%
Max Revenue beat(2)10.31%
Revenue beat(4)3
Avg Revenue beat(4)4.57%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)10.31%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.75%
EPS NY rev (1m)-270.37%
EPS NY rev (3m)-270.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.37
P/FCF 20.9
P/OCF 7.39
P/B 3.03
P/tB N/A
EV/EBITDA 8.95
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.08
FCFY4.78%
OCF(TTM)0.23
OCFY13.53%
SpS4.52
BVpS0.56
TBVpS-2.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.46%
ROE -70.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.01%
FCFM 1.78%
ROA(3y)-9.2%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 3.29
Debt/FCF 24.87
Debt/EBITDA 5.24
Cap/Depr 39.18%
Cap/Sales 3.26%
Interest Coverage N/A
Cash Conversion 65.42%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z 0.81
F-Score3
WACC10.13%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-259.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-117.78%
EPS Next Y-189.29%
EPS Next 2Y-47.6%
EPS Next 3Y-10.61%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.11%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%15.02%
Revenue Next Year3.55%
Revenue Next 2Y6.13%
Revenue Next 3Y6.94%
Revenue Next 5YN/A
EBIT growth 1Y-105.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.78%
EBIT Next 3Y25.55%
EBIT Next 5YN/A
FCF growth 1Y8.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.14%
OCF growth 3YN/A
OCF growth 5YN/A